In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Nucryst Pharmaceuticals makes appointment:

This article was originally published in Clinica

Executive Summary

Nucryst Pharmaceuticals, a Wakefield, Massachusetts-based company that specialises in nanocrystalline silver coatings for woundcare products (a range of which are marketed by Smith & Nephew), has appointed Thomas Gardner as chairman, president and CEO, effective immediately. Mr Gardner replaces Barry Heck (chairman), who remains as a director, and Scott Gillis (president and CEO), who is leaving the company.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts